Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Biomedical Informatics
|
October 21, 2015
High-throughput alternative splicing detection using dually constrained correspondence analysis (DCCA)
Florent Baty, Dirk Klingbiel, Francesco Zappa, et al.
Physical Review Letters
|
September 7, 2019
Black-Hole Remnants from Black-Hole-Neutron-Star Mergers
Francesco Zappa, Sebastiano Bernuzzi, Francesco Pannarale, et al.
Advances in Experimental Medicine and Biology
|
December 16, 2015
Target Therapy in Lung Cancer
Stefano Cafarotti, Filippo Lococo, Patrizia Froesh, et al.
Physical Review Letters
|
March 31, 2018
Gravitational-Wave Luminosity of Binary Neutron Stars Mergers
Francesco Zappa, Sebastiano Bernuzzi, David Radice, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
February 18, 2003
NAD(P)H: quinone oxidoreductase 1 expression in kidney podocytes
Francesco Zappa, Timothy Ward, Ennio Pedrinis, et al.
Journal of Translational Medicine
|
April 1, 2017
24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling
Florent Baty, Markus Joerger, Martin Früh, et al.
Acta Haematologica
|
February 11, 2010
Rapid anaemia control with epoetin: results of a Swiss survey on treatment of chemotherapy-induced anaemia
Razvan Popescu, Albert von Rohr, Domenique Piguet, et al.
Physical Review Letters
|
June 10, 2024
Neutrino Trapping and Out-of-Equilibrium Effects in Binary Neutron-Star Merger Remnants
Pedro Luis Espino, Peter Hammond, David Radice, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2015
Gene Expression Signatures Predictive of Bevacizumab/Erlotinib Therapeutic Benefit in Advanced Nonsquamous Non-Small Cell Lung Cancer Patients (SAKK 19/05 trial)
Anca Franzini, Florent Baty, Ina I Macovei, et al.
Clinical Lung Cancer
|
September 19, 2015
EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect
Nora Sahnane, Milo Frattini, Barbara Bernasconi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Biomedical Informatics
|
October 21, 2015
High-throughput alternative splicing detection using dually constrained correspondence analysis (DCCA)
Florent Baty, Dirk Klingbiel, Francesco Zappa, et al.
Physical Review Letters
|
September 7, 2019
Black-Hole Remnants from Black-Hole-Neutron-Star Mergers
Francesco Zappa, Sebastiano Bernuzzi, Francesco Pannarale, et al.
Advances in Experimental Medicine and Biology
|
December 16, 2015
Target Therapy in Lung Cancer
Stefano Cafarotti, Filippo Lococo, Patrizia Froesh, et al.
Physical Review Letters
|
March 31, 2018
Gravitational-Wave Luminosity of Binary Neutron Stars Mergers
Francesco Zappa, Sebastiano Bernuzzi, David Radice, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
February 18, 2003
NAD(P)H: quinone oxidoreductase 1 expression in kidney podocytes
Francesco Zappa, Timothy Ward, Ennio Pedrinis, et al.
Journal of Translational Medicine
|
April 1, 2017
24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling
Florent Baty, Markus Joerger, Martin Früh, et al.
Acta Haematologica
|
February 11, 2010
Rapid anaemia control with epoetin: results of a Swiss survey on treatment of chemotherapy-induced anaemia
Razvan Popescu, Albert von Rohr, Domenique Piguet, et al.
Physical Review Letters
|
June 10, 2024
Neutrino Trapping and Out-of-Equilibrium Effects in Binary Neutron-Star Merger Remnants
Pedro Luis Espino, Peter Hammond, David Radice, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2015
Gene Expression Signatures Predictive of Bevacizumab/Erlotinib Therapeutic Benefit in Advanced Nonsquamous Non-Small Cell Lung Cancer Patients (SAKK 19/05 trial)
Anca Franzini, Florent Baty, Ina I Macovei, et al.
Clinical Lung Cancer
|
September 19, 2015
EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect
Nora Sahnane, Milo Frattini, Barbara Bernasconi, et al.
Page
of 2